Circulating tumor DNA (ctDNA) as a biomarker for lung cancer: Early detection, monitoring...

X Wang, L Wang, H Lin, Y Zhu, D Huang, M Lai… - Frontiers in …, 2024 - frontiersin.org

Circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vehicles
(EVs) have received significant attention in recent times as emerging biomarkers and …

被引用次数：2 相关文章所有 8 个版本

[PDF] acs.org

Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers

M Mishra, R Ahmed, DK Das… - ACS Biomaterials …, 2024 - ACS Publications

Early detection of cancer is vital for increasing patient survivability chances. The three major
techniques used to diagnose cancers are instrumental examination, tissue biopsy, and …

HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma

Y Li, Y Wang, R Wu, P Li, Z Cheng - Scientific Reports, 2024 - nature.com

Chronic obstructive pulmonary disease (COPD) is often associated with lung squamous cell
carcinoma (LUSC), which has the same etiology (smoking, inflammation, oxidative stress …

Liquid biopsy for early detection of lung cancer

M Bibikova, J Fan - Chinese Medical Journal Pulmonary and Critical …, 2023 - mednexus.org

Lung cancer is the leading cause of cancer-related mortality worldwide. Early cancer
detection plays an important role in improving treatment success and patient prognosis. In …

被引用次数：3 相关文章所有 2 个版本

[PDF] iospress.com

Lung cancer biomarkers: Raising the clinical value of the classical and the new ones

S Holdenrieder, HH van Rossum… - Tumor …, 2024 - content.iospress.com

Blood-based diagnostics for lung cancer support the diagnosis, estimation of prognosis,
prediction, and monitoring of therapy response in lung cancer patients. The clinical utility of …